337 related articles for article (PubMed ID: 19217486)
1. Angiogenic factors and preeclampsia.
Steinberg G; Khankin EV; Karumanchi SA
Thromb Res; 2009; 123 Suppl 2():S93-9. PubMed ID: 19217486
[TBL] [Abstract][Full Text] [Related]
2. Pre-eclampsia: clinical manifestations and molecular mechanisms.
Baumwell S; Karumanchi SA
Nephron Clin Pract; 2007; 106(2):c72-81. PubMed ID: 17570933
[TBL] [Abstract][Full Text] [Related]
3. [Angiogenic factors and their role in pathogenesis and prediction of preeclampsia].
Stepan H; Jank A
Z Geburtshilfe Neonatol; 2009 Jun; 213(3):101-5. PubMed ID: 19536710
[TBL] [Abstract][Full Text] [Related]
4. Angiogenic factors and preeclampsia.
Tjoa ML; Levine RJ; Karumanchi SA
Front Biosci; 2007 Jan; 12():2395-402. PubMed ID: 17127249
[TBL] [Abstract][Full Text] [Related]
5. Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia.
Silasi M; Cohen B; Karumanchi SA; Rana S
Obstet Gynecol Clin North Am; 2010 Jun; 37(2):239-53. PubMed ID: 20685551
[TBL] [Abstract][Full Text] [Related]
6. Angiogenic factors and pre-eclampsia: an early marker is needed.
Stepan H
Clin Sci (Lond); 2009 Feb; 116(3):231-2. PubMed ID: 19032146
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus-induced mirror syndrome associated with elevated levels of circulating antiangiogenic factors.
Rana S; Venkatesha S; DePaepe M; Chien EK; Paglia M; Karumanchi SA
Obstet Gynecol; 2007 Feb; 109(2 Pt2):549-52. PubMed ID: 17267891
[TBL] [Abstract][Full Text] [Related]
8. An analysis on the roles of angiogenesis-related factors including serum vitamin D, soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF) in the diagnosis and severity of late-onset preeclampsia.
Cim N; Kurdoglu M; Ege S; Yoruk I; Yaman G; Yildizhan R
J Matern Fetal Neonatal Med; 2017 Jul; 30(13):1602-1607. PubMed ID: 27658884
[TBL] [Abstract][Full Text] [Related]
9. Angiogenic biomarkers for prediction of maternal and neonatal complications in suspected preeclampsia.
Moore AG; Young H; Keller JM; Ojo LR; Yan J; Simas TA; Maynard SE
J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2651-7. PubMed ID: 22861812
[TBL] [Abstract][Full Text] [Related]
10. Preeclampsia: the role of angiogenic factors in its pathogenesis.
Wang A; Rana S; Karumanchi SA
Physiology (Bethesda); 2009 Jun; 24():147-58. PubMed ID: 19509125
[TBL] [Abstract][Full Text] [Related]
11. New aspects in the pathophysiology of preeclampsia.
Davison JM; Homuth V; Jeyabalan A; Conrad KP; Karumanchi SA; Quaggin S; Dechend R; Luft FC
J Am Soc Nephrol; 2004 Sep; 15(9):2440-8. PubMed ID: 15339993
[TBL] [Abstract][Full Text] [Related]
12. Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies.
Powers RW; Jeyabalan A; Clifton RG; Van Dorsten P; Hauth JC; Klebanoff MA; Lindheimer MD; Sibai B; Landon M; Miodovnik M;
PLoS One; 2010 Oct; 5(10):e13263. PubMed ID: 20948996
[TBL] [Abstract][Full Text] [Related]
13. A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia.
Sela S; Itin A; Natanson-Yaron S; Greenfield C; Goldman-Wohl D; Yagel S; Keshet E
Circ Res; 2008 Jun; 102(12):1566-74. PubMed ID: 18515749
[TBL] [Abstract][Full Text] [Related]
14. Angiogenic factors for the prediction of preeclampsia in high-risk women.
Moore Simas TA; Crawford SL; Solitro MJ; Frost SC; Meyer BA; Maynard SE
Am J Obstet Gynecol; 2007 Sep; 197(3):244.e1-8. PubMed ID: 17826405
[TBL] [Abstract][Full Text] [Related]
15. Angiogenic factors in the pathogenesis of preeclampsia.
Yuan HT; Haig D; Ananth Karumanchi S
Curr Top Dev Biol; 2005; 71():297-312. PubMed ID: 16344109
[TBL] [Abstract][Full Text] [Related]
16. New markers in preeclampsia.
Hertig A; Liere P
Clin Chim Acta; 2010 Nov; 411(21-22):1591-5. PubMed ID: 20659441
[TBL] [Abstract][Full Text] [Related]
17. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.
Maynard SE; Min JY; Merchan J; Lim KH; Li J; Mondal S; Libermann TA; Morgan JP; Sellke FW; Stillman IE; Epstein FH; Sukhatme VP; Karumanchi SA
J Clin Invest; 2003 Mar; 111(5):649-58. PubMed ID: 12618519
[TBL] [Abstract][Full Text] [Related]
18. Circulating Levels of sFlt1 Splice Variants as Predictive Markers for the Development of Preeclampsia.
Souders CA; Maynard SE; Yan J; Wang Y; Boatright NK; Sedan J; Balyozian D; Cheslock PS; Molrine DC; Simas TA
Int J Mol Sci; 2015 Jun; 16(6):12436-53. PubMed ID: 26042465
[TBL] [Abstract][Full Text] [Related]
19. Novel splice variants of sFlt1 are upregulated in preeclampsia.
Heydarian M; McCaffrey T; Florea L; Yang Z; Ross MM; Zhou W; Maynard SE
Placenta; 2009 Mar; 30(3):250-5. PubMed ID: 19147226
[TBL] [Abstract][Full Text] [Related]
20. Placental ischemia and breast cancer risk after preeclampsia: tying the knot.
Gingery A; Bahe EL; Gilbert JS
Expert Rev Anticancer Ther; 2009 May; 9(5):671-81. PubMed ID: 19445583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
